You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 9, March 1, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the Clinical Center of the National Institutes of Health
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human T-Cell Lymphotropic Virus Type I—Associated Adult T-Cell Leukemia

The Joseph Goldberger Clinical Investigator Lecture

Thomas A. Waldmann, MD

JAMA. 1995;273(9):735-737.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SELECTED CASE

A 37-year-old Jamaican woman developed a generalized erythematous maculopapular rash. She had a peripheral white blood cell (WBC) count of 37x109/L, 75% of which were malignant T cells with convoluted nuclei. The diagnosis of human T-cell lymphotropic virus type I (HTLV-I)—related adult T-cell leukemia/lymphoma (ATL) was supported by high titers of antibodies to HTLV-I in the peripheral blood. The patient was referred to the National Institutes of Health for treatment.

Results of physical examination on admission were normal, with the exception of a generalized nonpuritic maculopapular skin rash. The patient manifested overt leukemia with a peripheral WBC count of 32.6 x109/L, 83% of which were malignant T cells. The phenotype of the malignant cells was CD3+, CD4+, CD8-, CD7-, and CD25+. The serum concentration of soluble CD25 was elevated to 3645 units (normal geometric mean 235, with 95% confidence interval of 112 to 502 . . . [Full Text PDF of this Article]


Author Affiliations

From the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md.


Footnotes

Reprint requests to the Metabolism Branch, National Cancer Institute, Bldg 10, Room 4N115, National Institutes of Health, Bethesda, MD 20892 (Dr Waldmann).

Grand Rounds at the Clinical Center of the National Institutes of Health section editors: John I. Gallin, MD, the Clinical Center of the National Institutes of Health, Bethesda, Md; David S. Cooper, MD, Contributing Editor, JAMA.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.